about
Aristolochic acid-associated urothelial cancer in TaiwanMutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinomaAsia prostate cancer study (A-CaP Study) launch symposium.The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma.Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.Aristolochic Acid in the Etiology of Renal Cell Carcinoma.No increased risk of coronary heart disease for patients receiving androgen deprivation therapy for prostate cancer in Chinese/Taiwanese men.Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation.Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.Emphysematous pyelonephritis: clinical characteristics and prognostic factors.Response to "Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists".The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.Perioperative changes in TGF-β1 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer.The effect of tumor location on oncologic outcomes in patients with upper urinary tract urothelial carcinoma stratified by pathologic stage.Proactive rectal warming during total-gland prostate cryoablationStopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancerClinical outcome of Taiwanese men with metastatic prostate cancer compared with other ethnic groupsUsing age-referenced prostate-specific antigen percentile to predict survival outcomes in screened Taiwanese menDiabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinomaPrognostic value of saturated prostate cryoablation for localized prostate cancer
P50
Q24616582-B758D288-C2FD-418D-BC62-824B41794BE6Q34362617-51C96BC0-ADD5-42D9-B3D6-14B1FB4E6039Q35271198-00DA1813-7A79-43E8-A28C-D7AAA28B31E0Q36149569-DE34D3DC-F0E8-4751-B04F-C65BB96FD0D2Q36259082-2067E3F6-F143-44D0-9170-F83F143D8AA5Q36505864-BB4384F6-61D0-419F-8679-EC6C9AD4496AQ37564385-5782B9C1-CC0E-41C3-9421-5404541C243FQ38698536-01A5F2FE-EDA7-4C5D-87B4-5D6C78823207Q39459925-5A34FC21-4297-46AF-9BB8-8EBD23AEFD56Q40164167-E5D82189-BEF8-484E-A1A3-1C129DCD7A2CQ41486881-3F2193CF-7917-4BE9-ABE4-79CAE6AD0EB2Q44132072-EA6FCA5E-FC3F-4DEC-BE72-9DF138298200Q44323061-27430EAE-6E7B-45EE-A986-B586411D2FF2Q45423493-8F1DEEC8-ED31-4782-9883-1BE108FD1EC7Q45866550-4FC9AC83-4EB9-472D-A5A1-E310425A0976Q47171613-E34D53B6-A649-4B59-8617-63D7DFFD2996Q51075784-0BBD07C0-1996-41A8-A7A8-AF43FB96422AQ51723016-0A9E9A0F-B317-4CB4-A181-F680AE82258FQ53352422-EE50029E-DBAF-4548-86E3-3BCDC460C096Q57095485-EAED5BA2-09E9-4EB9-AEBF-75352430C6CEQ59187246-815D68D0-01E6-432A-B293-E78B60F257CCQ80970748-A918C07A-C8F1-4BEE-A23C-CB4D80734C42Q84985743-7EBCC4A3-D0A1-4D85-B196-FF3368C5B294Q85896441-65E6390D-2C2A-412F-B255-1B1F3A3385EAQ86435821-0BCEB40A-E38D-44CB-8C5E-51B68549E585
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4921-5315
@en
name
Chung-Hsin Chen
@ast
Chung-Hsin Chen
@en
Chung-Hsin Chen
@es
Chung-Hsin Chen
@nl
type
label
Chung-Hsin Chen
@ast
Chung-Hsin Chen
@en
Chung-Hsin Chen
@es
Chung-Hsin Chen
@nl
prefLabel
Chung-Hsin Chen
@ast
Chung-Hsin Chen
@en
Chung-Hsin Chen
@es
Chung-Hsin Chen
@nl
P106
P1153
25921037500
P31
P496
0000-0002-4921-5315